Opinion: STAT+: A bill is supposed to protect U.S. biotech from Chinese competition. But there’s a loophole

How 1 sources are covering this

• STATCenter·1h ago

  Opinion: STAT+: A bill is supposed to protect U.S. biotech from Chinese competition. But there’s a loophole

  “Biotech industry leaders must forge a new geographic path before heavy-handed legislation forces the issue,” write executives at Optimapharm.

  Read at STAT →